摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-Methoxyanilino)-6-methylsulfonylquinoline-3-carbonitrile | 1145724-66-8

中文名称
——
中文别名
——
英文名称
4-(3-Methoxyanilino)-6-methylsulfonylquinoline-3-carbonitrile
英文别名
——
4-(3-Methoxyanilino)-6-methylsulfonylquinoline-3-carbonitrile化学式
CAS
1145724-66-8
化学式
C18H15N3O3S
mdl
——
分子量
353.401
InChiKey
ISPPGDBKNNWUCX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    4-(3-Methoxyanilino)-6-methylsulfonylquinoline-3-carbonitrile 在 palladium on activated charcoal 、 氢气 作用下, 以 乙醇 为溶剂, 生成
    参考文献:
    名称:
    Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
    摘要:
    Crystallography-driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of a series of quinoline derivatives that were highly potent and selective inhibitors of PDE4 with a good pharmacokinetic profile in the rat. Quinolines 43 and 48 have potential as oral medicines for the treatment of COPD.
    DOI:
    10.1016/j.bmcl.2009.01.045
  • 作为产物:
    描述:
    4-[(3-Methoxyphenyl)amino]-6-(methylsulfonyl)quinoline-3-carboxamide 在 三氟乙酸酐 作用下, 生成 4-(3-Methoxyanilino)-6-methylsulfonylquinoline-3-carbonitrile
    参考文献:
    名称:
    Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
    摘要:
    Crystallography-driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of a series of quinoline derivatives that were highly potent and selective inhibitors of PDE4 with a good pharmacokinetic profile in the rat. Quinolines 43 and 48 have potential as oral medicines for the treatment of COPD.
    DOI:
    10.1016/j.bmcl.2009.01.045
点击查看最新优质反应信息